openPR Logo

Press Releases from futurosolution@biznaver.com (1 total)

iPSC Derived Cardiomyocytes and 3D Tissue Contractility Analysis | NEXEL

NEXEL Co., Ltd. is committed to becoming a world-class biotech company. Its aim is to develop innovative new therapies to help patients and provide tools

Go To Page: